Former president Jimmy Carter’s charity has helped transform Guinea worm from a disease that used to infect millions to one that infects fewer than a dozen

Experiments that make viruses more virulent or contagious present significant risks. Are those risks worth the rewards?

The rate of antipsychotic drug use in nursing homes has remained stubbornly high. Experts are concerned about misuse.

Twenty years after meeting at HMS, two alumni are at the leading edge of efforts to use minimally invasive neural implants to improve human health

Scientists are debating whether microscopic blood clots are responsible for the wide range of symptoms in long Covid.

The EPA is set to limit PFAS in drinking water to barely detectable levels. Can water utilities meet the standard?

Access to pediatric COVID vaccines has been hampered by a shortage of doses, higher costs to providers and parental skepticism

Tremendous Sargassum Blooms Challenge Caribbean and Atlantic Communities

Current monoclonal antibodies fail against COVID virus variants, so drugmakers want to use a fast-track test for new ones

Burning piles of used gloves, test kits and syringes release toxic pollutants. But there are ways to improve medical recycling

A new study in Mexico shows that non-mRNA vaccines like the Russian version can be as effective as mRNA vaccines like Pfizer if the patient has previously been infected with SARS-CoV-2.

A group of academics claim the president of EcoHealth Alliance has misled the public amid Covid origins investigations.

The U.S.’s top infectious disease specialist describes a new Biden administration program to develop and test antivirals—and what he’s most worried about as the nation reopens

More than a year into the SARS-CoV-2 pandemic, some scientists say the possibility of a lab leak never got a fair look.

A treatment from World War I is making a comeback in the struggle to beat deadly multidrug-resistant infections